Drug Trial Radar · NCT02161757
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Last checked: Nov 20, 2026Latest source record: Aug 28, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,207
Actual
Start
Jun 13, 2014
Primary completion
Feb 28, 2017
Study completion Jul 18, 2017
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jun 12, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist
Conditions
- Uncontrolled Asthma
Interventions
TralokinumabBiological
Subcutaneous injection
PlaceboOther
Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualised Asthma Exacerbation Rate (AAER) up to Week 52Time frame: Baseline (Week 0) up to Week 52
Locations
243 sites in 15 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Phoenix, Arizona
Research Site
Arcadia, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Newport Beach, California
Research Site
Poway, California
Research Site
San Jose, California
Research Site
Tustin, California
Research Site
Wildomar, California
Research Site
Colorado Springs, Colorado
Research Site
Denver, Colorado
Research Site
Denver, Colorado
Research Site
New Haven, Connecticut
Research Site
Clearwater, Florida
Research Site
Coral Gables, Florida
Research Site
Cutler Bay, Florida
Research Site
Fort Lauderdale, Florida
Research Site
Hialeah, Florida
Research Site
Hialeah, Florida
Research Site
Homestead, Florida
Research Site
Homestead, Florida
Research Site
Jacksonville, Florida
Research Site
Kissimmee, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Ormond Beach, Florida
Research Site
Pembroke Pines, Florida
Research Site
Winter Park, Florida
Research Site
Albany, Georgia
Showing 40 of 243 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.